RBC Capital analyst Jon Arfstrom maintained a Hold rating on First Financial Bancorp (FFBC – Research Report) on January 24 and set a price ...

RBC Capital analyst Brad Heffern maintained a Buy rating on Realty Income (O – Research Report) today and set a price target of $62.00. The ...

RBC Capital Markets showed confidence in American Express Company (NYSE:AXP) by increasing its price target from $330.00 to ...

RBC Capital Markets adjusted its outlook on STAG Industrial, a real estate investment trust listed on the New York Stock ...

Though Boeing is poised on 28 January to report a massive loss for 2024, some analysts suspect the company's financial and ...

Wall Street investment bank Goldman Sachs is a man down in its small-cap equity research team. Street Talk understands ...

Brian Niccol, who is four months into his new role, has set forth a raft of measures to improve the coffee chain's business.

SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $7.1 which represents a slight increase of $0.08 or 1.14% from the prior close of $7.02. The stock opened at $7.02 and touched ...

To address the region’s growing capacity needs the region’s airport authority will issue $1 billion of investment-grade municipal debt on Tuesday, Jan. 28, marking the agency’s largest bond sale ever ...

Trump's announcement of imposing tariffs and travel bans on Colombia with countermeasures from Colombian President Petro points to the abiding risk of U.S. tariffs even beyond U.S.-China geopolitical ...

Blue-chip stocks are some of the best choices for creating the perfect portfolio.

Here’s why any drop in Royal Bank stock in 2025 could be an opportunity for long-term investors to buy it at a bargain.